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A growth inhibitory role in skin development for the NF-jB proteins has been established in recent years. We have
previously shown that inhibition of NF-jB by overexpression of degradation-resistant IjB-a in the skin results in
the development of squamous cell carcinomas (SCC). In this paper, we characterize the progressive skin disease
leading to cancer development in mice with inhibited NF-jB signaling in the skin. Increased proliferation and a
strong inﬂammatory response were evident in transgenic skin. A mixed inﬂammatory cell inﬁltrate dominated by
polymorphonuclear leukocytes was observed in concurrence with an upregulation of the proinﬂammatory cytokine
tumor necrosis factor-a. This genetically engineered mouse mutation may be a useful tool to test the efﬁcacy of
cytokine therapies for SCC in the future.
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The NF-kB proteins are a family of transcription factors that
reside in the cytoplasm of the cell in an inactive state. They
are retained in the cytoplasm by members of a family of
inhibitory IkB proteins. The NF-kB proteins are activated by
a wide array of stimuli including cytokines, radiation, DNA
damaging agents and cellular stress. They are involved in
the regulation of many cellular functions such as cell growth
and immune response, apoptosis, and neoplastic trans-
formation (Pahl, 1999). Upon activation, IkB is rapidly
phosphorylated by the IkB kinase (IKK) complex and
degraded allowing NF-kB to translocate into the nucleus
(Karin and Ben-Neriah, 2000).
Involvement of the NF-kB transcription factors in skin
physiology has been defined in recent years. NF-kB plays a
role in regulation of epidermal proliferation. Earlier studies
using mice overexpressing a constitutively nuclear form of
the NF-kB subunit p50 in the skin showed growth inhibition
of the epidermis whereas mice expressing its inhibitory
partner, IkB-a, developed hyperplasia (Seitz et al, 1998).
The researchers used a keratin 14 promoter to drive IkB-a
transgene expression resulting in death of the mice within 7
d post partum (dpp). In our previous studies, using an IkB-a
transgene driven by a keratin 5 promoter, mice survived to
adulthood and developed cutaneous squamous cell carci-
nomas (SCC) (van Hogerlinden et al, 1999).
Inhibition of the NF-kB pathway by targeted deletion of
IKKa, a subunit of the IkB kinase complex, similarly lead to
the development of epidermal hyperplasia (Hu et al, 1999;
Li et al, 1999; Takeda et al, 1999). These mice also had
defects in terminal differentiaton, which was independent of
NF-kB (Hu et al, 2001).
A link between the NF-kB pathway and human skin
disease was provided by results showing that female mice
heterozygous for IKKg deficiency, the regulatory subunit of
the IkB kinase complex, develop a skin phenotype similar
to the human X-linked disorder incontinentia pigmenti (IP)
(Makris et al, 2000; Schmidt-Supprian et al, 2000). Most
human cases of IP are due to mutations in the IKKg gene
(Smahi et al, 2000). In addition, X-linked anhidrotic ecto-
dermal dysplasia with immunodeficiency is caused by
impaired NF-kB signaling due to mutations in IKKg (Zonana
et al, 2000; Doffinger et al, 2001).
Recently, mice with an epidermis-specific deletion of
IKKb developed epidermal hyperplasia and severe inflam-
matory skin disease caused by a tumor necrosis factor
(TNF)-a mediated, ab T cell-independent inflammatory res-
ponse (Pasparakis et al, 2002).
To elucidate the mechanism of growth inhibition by NF-
kB, Seitz et al, overexpressed NF-kB subunits in cultured
keratinocytes and observed that cell cycle progression
was inhibited in association with the selective induction of
the cell cycle inhibitor protein p21 (Seitz et al, 2000).
Moreover, we have recently shown that inhibition of NF-kB
signaling in mouse skin generates keratinocytes that are
unable to arrest the cell cycle in response to DNA damage
induced by g-irradiation (Van Hogerlinden et al, 2002). In this
paper, we have studied progressive epidermal dysplasia
leading to SCC development in IkB-a transgenic mice
using a K5 promoter and characterized the inflammatory
response.
Abbreviations: IKK, IkB kinase; SCC, squamous cell carcinomas;
dpp, days post partum; wpp, weeks post partum; TNF, tumor
necrosis factor; PBS, phosphate-buffered saline
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Results
Histopathology of transgenic skin In our previous stu-
dies, inhibition of NF-kB signaling in mouse skin by
overexpression of a constitutively stable form of IkB-a
leads to the development of SCC of the skin. To
characterize the longitudinal progression of the cancer
development in the transgenic animals, we now have
systematically examined skin from transgenic and wild-
type control mice at different ages. Corresponding to
macroscopic observations of the skin lesions in mutant
mice, microscopic evaluation demonstrated that the le-
sions, which progressed with age, were primarily found on
the tail and the dorsal lumbar area, adjacent to the tail head
(Fig 1).
The initial change, slight hyperplasia of interfollicular
epidermis, was evident 12 dpp in the tail skin. The
epithelium was flat with few basal dyskeratotic keratino-
cytes, moderate hypergranulosis and discrete orthokerato-
tic hyperkeratosis with some parakeratotic mounds.
By 15 dpp the epidermis demonstrated increased
numbers of mitotic figures and dyskeratotic cells (Fig 2).
These changes became more prominent at 18 and 21 dpp
with additional trichilemmal metaplasia of the interfollicular
epithelium. At this age, the follicular pore and infundibulum
showed alterations with plugging and loss of hair shafts.
Hair follicles were in telogen associated with moderate
infundibular hyperplasia (Fig 3). Macroscopically, this pre-
sented as hair loss and thinning of the coat.
At 30 dpp these changes had progressed to a contin-
uous surface epithelium with trichilemmal differentiation,
loss of proper follicular structures, and concomitant sug-
gestive dysplasia (data not shown).
Four wk later, that is, 8 wk post partum (wpp), the surface
epithelium of the tail was markedly dysplastic with loss of
maturation including suprabasal mitoses and cellular atypia,
retaining the trichilemmal differentiation. The dysplastic
epithelium formed rounded rete pegs and invaginations,
reminiscent of follicular structures.
At 16 wpp both mutant mice had developed an infiltrative
well-differentiated SCC with a pseudopapillary configura-
tion, the female on the tail and the male on the lower back,
close to the tail head (Fig 4).
The non-lesional dorsal and ventral skin was normal at
all other ages in transgenic mice except for scattered
dyskeratotic basal keratinocytes.
The observed phenotype is fully penetrant. All transgenic
mice develop the skin disease over time.
Increased proliferation in transgenic skin The progres-
sion of hyperplasia into subsequent dysplasia and neopla-
sia suggested an increased proliferation rate in transgenic
mouse skin. To verify this, we examined the expression of
Ki-67, a nuclear protein expressed by proliferating cells
(Schluter et al, 1993). Increased numbers of Ki-67 positive
cells were observed in the hyperplastic epithelium at 12 dpp
with positive cells found also in suprabasal layers of
the epidermis. The increased proliferation rate persisted
through dysplastic lesions and SCC (Fig 5).
Figure 1
Tail skin of normal male mice at 12 dpp (A), 18 dpp (C), 8 wpp (E),
and 16 wpp (G) exhibited mild thinning of the epidermis and no
dermal inflammation. By contrast, age- and gender-matched K5-
IjB-a mice had progressive thickening of the epidermis with
dyskeratosis (arrows). Older mice (8 and 16 wpp, F, H) developed
progressive dysplastic changes and parakeratosis with mild dermal
inflammation. H&E. Bar¼ 50 mm.
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To examine the mitotic rate in transgenic skin we used
immunohistochemical analysis to stain cells expressing
phospho-Histone H3, a marker for mitotic cells (Hendzel
et al, 1997). An increased number of mitoses was found
already at 12 dpp in transgenic mouse skin lesions. The
number of mitoses increased during the following progres-
sing stages with high numbers of mitotic cells seen in
dysplastic and neoplastic lesions at 8 and 16 wpp,
respectively (Fig 5).
Characterization of the inﬂammatory inﬁltrate The
epithelial alterations were accompanied by an inflammatory
cell infiltrate in the underlying dermis, initially sparse and
patchy, with increasing cellularity and a more band-like
configuration as the lesions progressed.
The CD3 reactive cells, that is, putative T-lymphocytes,
were few in the controls, located basally in the epidermis
and scattered in the dermis. In the mutant mice, lesional
epithelium contained sparse reactive cells, basally and
suprabasally, most of which were dendritic as well as a few
reactive cells in the adjacent dermis. The number of reactive
cells seemed more or less constant regardless of the
severity of the lesion, that is, did not increase in proportion
with the cellularity of the dermal infiltrate (Fig 6A).
The B220 reactive cells, that is, putative B-lymphocytes,
were only found in the dermis in the controls and in a very
limited number. In the mutants, however, B220þ cells were
demonstrated in lesional epithelium, a few already in the
hyperplastic areas 12 dpp increasing to a moderate number
in the dysplastic epithelium 8 wpp, then decreasing in
the infiltrative squamous carcinoma 16 wpp. The number
of B220þ cells in the dermal infiltrate followed a similar
pattern, that is, peaking at 8 wpp (Fig 6A).
Neutrophil leukocytes, as defined by myeloperoxidase
reactivity, were occasionally found in the dermis in the
control mice. In mutant mice, a few neutrophils were evident
in the subepidermal dermis adjacent to hyperplastic foci at
12 and 15 dpp. From 18 dpp the reactive cells diffusely
infiltrated the hyperplastic epidermis, also forming micro-
abscesses. Neutrophils and cellular debris were eventually
found in the cornified layer. In the dermal infiltrate the
neutrophils increased up to 16 wpp when they dominated
the infiltrate, amounting to approximately 50% of inflam-
matory cells adjacent to the SCC (Fig 6B).
Eosinophils were identified by Luna’s stain. Only cells
with lobulated nuclei and intense eosinophilic, sometimes
granular, cytoplasm were counted. Polynucleated cells not
fulfilling this criterium could represent degranulated eosi-
nophils. With this reservation, the eosinophils mirrored the
neutrophil infiltrate as to occurrence and distribution, but
were at all time points fewer in number (Fig 6B).
Mast cells were identified as metachromatic cells by
toluidine blue staining. In control mice, a few evenly
distributed mast cells were present in the dermis, as
expected. In the mutant mice an initially slight and later on
moderate increase was found, in proportion to the overall
increase of leukocytes in the dermal infiltrate (Fig 6B).
In conclusion, the composition of the dermal inflamma-
tory cell infiltrate adjacent to the epidermal changes was
relatively constant throughout evolution of the disease
phenotype. The polymorphic leukocytes were the predomi-
nant cell type, dominated by myeloperoxidase positive
forms as in the overlying epithelial lesion whether hyper-
plastic, dysplastic, or neoplastic. B220þ B cells exceeded
the CD3þ T cells in number, both in the epidermal infiltrate
and in the dermis. The mast cells, limited to the dermis,
increased in number in proportion to the degree of overall
inflammation. The dermis immediately below the epidermis
developed various degrees of fibrosis.
Expression of terminal differentiation markers Keratins
1 and 10 are normally expressed in suprabasal epidermis
and infundibular keratinocytes. In transgenic mice, expres-
Figure 2
Tail skin from a male K5-IjB-a transgenic mouse at 15 dpp
exhibited marked hyperplasia and numerous dyskeratotic kerati-
nocytes (arrows) in the basal component with a mild sub-
epidermal infiltrate of granulocytes and B cells. H&E. Bar¼50 mm.
Figure 3
Tail skin of female mice at 21 dpp. The littermate control skin had
normal epidermis, an anagen stage hair follicle, and normal non-
inflamed dermis (A). By contrast, transgenic mouse skin had moderate
to severe epidermal hyperplasia with dyskeratosis, orthokeratotic
hyperkeratosis, and mild dermal inflammation (B). Note that hair
follicles are in telogen associated with moderate infundibular hyper-
plasia (arrow). H&E. Bar¼50 mm.
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sion increased to involve all subrabasal layers (Fig 7A).
Keratin 6 is normally only expressed in the inner layer of the
outer root sheath of the hair follicle. Diffuse suprabasal
expression was evident in mutant mice with hyperplastic,
dysplastic, and neoplastic epidermis (Fig 7A). Keratins 5
and 14 are normally limited to basal cells in the epidermis
and outer root sheath of the hair follicle. Keratin 14 is also
expressed in terminally differentiated sebocytes and some
of the lower layers of suprabasal cells. In transgenic mice
there were no expression changes for keratin 5 but keratin
14 was expressed throughout the epidermis (Fig 7A).
Filaggrin, loricrin, and involucrin are normally expressed
in the stratum granulosum. In mutant mice expression
increased in proportion to the thickening of the stratum
granulosum. Involucrin was expressed in a patchy pattern in
mutant mice (Fig 7B).
Increased expression of TNF-a in transgenic skin TNF-a
is expressed in keratinocytes and can attract neutrophils
(Sayers et al, 1988; Kock et al, 1990; Kolde et al, 1992). The
inflammation observed in mice with an epidermis-specific
deletion of IKKb was shown to be TNF dependent
(Pasparakis et al, 2002). TNF-a has also been proposed
as an endogenous tumor promotor since mice lacking TNF-
a or TNF receptor 1 or 2 are resistant to chemical or UV-
induced carcinogenesis (Moore et al, 1999; Suganuma et al,
1999; Starcher 2000). For those reasons TNF-a expression
patterns were evaluated.
Increased TNF-a expression was detected at 12 dpp in
transgenic mouse epidermis. Expression increased pro-
gressively in dysplastic keratinocytes with some expression
in subpopulations of infiltrating cells (Fig 8). The expres-
sion pattern showed a juxtanuclear distribution, commonly
observed for cytokine producing cells (Litton et al, 1996).
Discussion
In this study, we have shown the progressive development
of SCC in mouse skin with inhibited NF-kB signaling. A
strong inflammatory response was observed in the hyper-
plastic and dysplastic phases concurrent with upregulated
TNF-a expression.
A unique anti-proliferative role of NF-kB in the epidermis
has been demonstrated in the past few years. Whereas
NF-kB functions as a promoter of cell proliferation in the
immune system, several studies have shown that the effect
is opposite in the epidermis. Data showed that sustained
NF-kB activity inhibits the proliferation of epidermal cells
whereas genetically modified mice overexpressing IkB-a,
resulting in NF-kB inhibition, develop epidermal hyperplasia
and cancer (Seitz et al, 1998; van Hogerlinden et al, 1999).
Figure 5
Increased proliferation in transgenic
skin. Expression of the proliferation mar-
ker Ki-67 was examined in wild-type
control (WT) or transgenic (TG) tail skin
at different ages, as indicated. Mitotic
cells were detected by examining the
expression of phospho-Histone H3 in
wild-type (WT), or transgenic (TG) skin at
different ages. Bar¼ 50 mm.
Figure 4
Hyperplasia and dysplasia progressed into
infiltrative squamous cell carcinoma in the tail
skin of a female K5-IjB-a mutant mouse at 16
wpp (A); note moderate cellular pleomorph-
ism and deep cornification exhibiting atypical
parakeratosis (arrow, B) and tumor infiltration
of a small superficial vessel (arrow, C). Wild-
type control skin is shown in (D). H&E. Bar¼
50 mm.
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Figure 6
Cutaneous inflammation in transgenic
mice. (A) B cells (B220), T cells (CD3)
and (B) neutrophils (myeloperoxidase),
eosinophils (Luna stain), and mast cells
(toluidine blue stain) increased with age
and epidermal thickness in transgenic
mice (TG) but remained scarce in wild-
type control (WT) mouse tail skin. Note
that mast cells accumulated under the
epidermis in 16-wk-old transgenic mice.
Bar¼ 50 mm.
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Demonstrating relevance to human cancer, a recent
paper by Dajee et al, shows that stable IkB-a, retrovirally
inserted into human keratinocytes together with an acti-
vated Ras, produces tumors resembling human SCC when
grafted onto immune-deficient mice (Dajee et al, 2003).
Recently, the connection between inflammation and
cancer development has been highlighted, since a growing
number of studies indicate that inflammation may act as an
endogenous tumor promotor (Coussens and Werb, 2002).
The inflammatory cells can have a tumor-promoting
effect by secreting proteolytic enzymes, cytokines and
chemokines, which act mitogenic for neoplastic cells and
endothelial cells involved in angiogenesis and lymphangio-
genesis. Infiltrating cells can also induce DNA damage
through generation of reactive oxygen and nitrogen species
(Coussens and Werb, 2002).
In this scenario, the increased proliferation observed in
the K5-IkB-a mice alone is not sufficient for cancer
development, but sustained cell proliferation in an environ-
ment rich in inflammatory cells, growth factors, and DNA-
damage-promoting agents, can contribute to the observed
tumorigenesis.
A cytokine receiving much attention as a major con-
tributing factor to skin tumor promotion is the inflammatory
cytokine TNF-a (Balkwill, 2002). Previous studies have
shown that genetic targeting of TNF-a or its receptor
inhibits DMBA/TPA- or UV-induced skin carcinogenesis
(Moore et al, 1999; Suganuma et al, 1999; Starcher, 2000).
In one of these studies, application of the tumor
promoter TPA was shown to result in upregulated expres-
sion of TNF-a in the epithelial compartment of the skin of
wild-type mice (Moore et al, 1999).
In our study, TNF-a was similarly found upregulated in
the epidermis of K5-IkB-a mice.
A recent paper shows that even an anti-TNF-a antibody
inhibits the development of skin tumors using DMBA/TPA
(Scott et al, 2003).
We believe that the increased inappropriate expression
of TNF-a in transgenic skin is important for the tumor
development. Preliminary results show that crossing of
K5-IkB-a mice to mice lacking TNF receptor 1 results in
prevention of the neoplastic phenotype (unpublished
results).
Interestingly, a recent study using mice with an epider-
mis-specific deletion of IKKb shows that these mice have
impaired NF-kB activation and develop an inflammatory-
based hyperplastic skin disease, which is dependent on
TNF-a since crossing of these mice with TNFR1-deficient
mice resulted in complete prevention of the phenotype
(Pasparakis et al, 2002).
Figure 7
Expression of epidermal differentiation markers. (A) The expression of keratins was examined by immunohistochemistry in wild-type (WT) or
transgenic (TG) tail skin from female mice at 30 dpp. An increased reactivity for keratin 1 was demonstrated suprabasally. Expression of the stress-
keratin 6 was observed in transgenic interfollicular epidermis. Increased expression of keratin 14 was shown in suprabasal cells whereas keratin 5
was restricted to the basal layer and seemed reduced compared with wild-type controls. (B) Expression of the terminal differentiation markers
filaggrin and loricrin, found in the stratum granulosum, was increased in transgenic skin whereas involucrin expression was patchy. Bar¼50 mm.
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However, we feel that increased proliferation in an
inflammatory environment is contributing to, but probably
not sufficient, for cancer development.
A number of spontaneous mouse mutants have epider-
mal hyperplasia associated with a mixed infiltrate. The flaky
skin (fsn) mutant mouse has a predominance of T cells but
mast cells line up beneath the basement membrane as seen
with these transgenic mice (Sundberg et al, 1997). Both
flaky skin and chronic proliferative dermatitis (cpdm) mutant
mice have various degrees of dermal eosinophilia (Pelsue
et al, 1998). However, affected skin does not progress to
SCC. Furthermore, transgenic mice using promoters that
drive TNF-a expression in the epidermis develop severe
dermatitis but no tumors (Cheng et al, 1992). Our previous
results showed a defect in cell cycle arrest following g-
irradiation in skin with inhibited NF-kB signaling (Van
Hogerlinden et al, 2002).
We believe that the enhanced proliferation together with
the strong inflammatory response, coupled with the inability
of transgenic keratinocytes to arrest the cell cycle in
response to DNA damage, all contribute to the observed
development of SCC.
In this model, highly proliferating keratinocytes are
subject to the tumor promoting effects of inflammation
orchestrated by growth factors provided by infiltrating cells
and also subject to DNA damage by the same inflammatory
cells. Due to the inherent defect in cell cycle regulation
these cells then fail to stop proliferating and can progress to
neoplasia.
One unexpected finding in this study was the B cell
epidermotropism seen in transgenic skin lesions. In hu-
mans, B cell epidermotropism is a rare event in cutaneuos B
cell lymphomas (Glusac et al, 1997). It shoud be noted
however, that some of these cells were dendritic and could
represent a subfraction of B220þ cells that do not belong to
the B cell lineage but are so called plasmacytoid dendritic
cells (Bjorck, 2002; Nikolic et al, 2002). These cells are
found in the skin and are involved in inflammatory skin
diseases (Wollenberg et al, 2002). They have also been
implicated in tumor development in ovarian cancer (Zou
et al, 2001).
It will be interesting in future studies to understand at a
molecular level the changes in gene expression at different
stages of tumor development in this mouse model.
To identify proteins downstream of NF-kB involved in
cell cycle regulation or inflammation that are differentially
expressed in transgenic skin we intend to use array
technology comparing wild-type and transgenic epidermal
RNA at different stages of neoplastic progression.
This may lead to a greater understanding of the way
NF-kB interacts with cell cycle components resulting in
excessive proliferation and poor DNA damage control, and
of the underlying mechanism for the inflammatory response
and increased TNF-a expression.
In conclusion, this transgenic mouse line is a valuable
model for human SCC and may in the future be very useful
for testing the efficacy of new therapeutic strategies.
Materials and Methods
Transgenic mice The FVB/N-Tg(KRT5-Nfkbia)3Rto (hereafter
referred to as K5-IkB-a) mice were generated as described
previously (van Hogerlinden et al, 1999). To study cancer
development and progression, mice were euthanized and necrop-
sied at 1, 3, 6, 9, 12, 15, 18, 21, 30, 56, and 112 dpp. One male and
one female mouse of each genotype (wild-type or transgenic) were
used per time point. Organs were fixed overnight in neutral
buffered formalin and embedded in paraffin.
Histology and immunohistochemistry Six mm serial sections
were cut, deparaffinized in xylene and passed through a graded
alcohol series prior to H&E as well as immunohistochemistry.
Endogenous peroxidase activity was blocked by incubation in
H2O2/methanol. After rinsing in H2O, the sections were micro-
waved until boiling at full effect þ 10 min at 300 W in 10 mM
sodium citrate buffer (pH 6.0) or 1 mM EDTA (pH 8.0). This antigen
retrieval was used on selected antibodies (indicated with an 
below). After washing in phosphate-buffered saline (PBS) sections
were blocked for 1 h in 5%–10% goat or rabbit serum in PBS. The
primary antibody in PBS containing 2% serum was applied for 1 h
at room temperature or overnight at 41C. After rinsing in PBS,
sections were incubated with biotinylated secondary antibody in
PBS, washed in PBS and incubated with streptavidin peroxidase
(Zymed, San Fransisco, California) or Vectastain Elite ABC reagent
(Vector Laboratories, Burlingame, California). Finally, after rinsing in
PBS, the reaction product was visualized using diaminobenzidine
and sections counterstained with Mayer’s hematoxylin. Primary anti-
bodies used were anti-Ki67 (Novocastra, Newcastle upon Tyne,
United Kindom) 1:700, anti-phospho Histone H3 (Upstate Bio-
technology, Lake Placid, New York) 1:750, anti-CD45R-B220 (BD
Pharmingen, San Diego, California) 1:50, anti-CD-3 (Dako, Glostrup,
Denmark) 1:1000, anti-myeloperoxidase (Dako, Glostrup, Den-
mark) 1:2000, anti-K1 (Covance Research Products, Denver,
Pennsylvania) 1:6000, anti-K5 (Covance Research Products,
Denver, Pennsylvania) 1:7000, anti-K6 (Covance Research Pro-
ducts, Denver, Pennsylvania) 1:6000, anti-K10 (Covance Research
Figure 8
Upregulation of TNF-a expres-
sion in transgenic skin. The
expression of the inflammatory
cytokine TNF-a was examined by
immunohistochemistry in wild-type
(WT) or transgenic (TG) mouse tail
skin at different ages, as indicated.
Strong expression of TNF-a was
present in transgenic keratinocytes
but was absent in wild-type skin. A
negative control section (-control),
using rat IgG1 isotype control,
showed no staining. Bar¼50 mm.
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Products, Denver, Pennsylvania) 1:2500, anti-K14 (Covance
Research Products, Denver, Pennsylvania) 1:6000, anti-filaggrin
(Covance Research Products, Denver, Pennsylvania) 1:35,000,
anti-loricrin (Covance Research Products, Denver, Pennsylvania)
1:5000, anti-involucrin (Covance Research Products, Denver,
Pennsylvania) 1:10,000, anti-TNF-a (BD Pharmingen, San Diego,
California) 1:25. As negative controls, all experiments were also
performed in the presence of equal concentrations of normal rabbit
IgG or rat/mouse Ig isotype control. Eosinophils were detected by
Luna’s method (Sheehan and Hrapchak, 1980) and mast cells by
acidified toluidine blue staining (pH 3.2). Mice were kept according
to Swedish national requirements and ethical permission was
obtained for all animal manipulations.
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